Liminatus Pharma LIMN
NASDAQ LIMN
$3.90 +0.11 (+2.90%)
At close: Oct 2, 2026 · 4:00 PM EDT

Liminatus Pharma (LIMN) Cash from Investing Activities (2024 - 2025)

Updated

Liminatus Pharma's Cash from Investing Activities was -$788,108 in FY2025, compared with -$2.85 million in FY2024.

Analysis

Liminatus Pharma (LIMN) Cash from Investing Activities (2024 - 2025) Analysis & Trends

  • Per Business Quant data, Cash from Investing Activities in earlier years was -$2.85 million in FY2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn -15.40 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn -1.11 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn -1.20 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn -5.60 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn -3.11 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn -2.91 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn -569.00 Mn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn -10.35 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn 2.11 Bn
10 Liminatus Pharma 4.37 Mn 4.37 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -13,108.00
Jun 30, 2025 -200,000.00
Mar 31, 2025 -575,000.00
Dec 31, 2024 -550,000.00
Sep 30, 2024 -800,000.00
API Access

Liminatus Pharma Cash from Investing Activities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-from-investing-activities&ticker=LIMN&period=max&api_key=YOUR_API_KEY